JCIC Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
JCIC Asset Management's BMY Position: Q3 2026 in Review
JCIC Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 875 shares — an estimated $53.1K sold.
JCIC Asset Management first reported a position in BMY in Q1 2020 and held it in 25 quarters. The position peaked at $154K in Q2 2021. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- JCIC Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- JCIC Asset Management sold 875 Bristol-Myers Squibb shares in Q3 2026, an estimated $53.1K.
- JCIC Asset Management first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 25 quarters.
- JCIC Asset Management's Bristol-Myers Squibb position peaked at $154K in Q2 2021.
- 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on JCIC Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.